|本期目录/Table of Contents|

[1]陈秋洪(综述),陈 雷,李 杰(审校).化脓性脊柱炎诊疗进展[J].福建医科大学学报,2020,54(01):62-66.
点击复制

化脓性脊柱炎诊疗进展(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第54卷
期数:
2020年01期
页码:
62-66
栏目:
综述
出版日期:
2020-02-28

文章信息/Info

Title:
-
文章编号:
1672-4194(2020)01-0062-05
作者:
陈秋洪(综述) 陈 雷 李 杰(审校)
福建医科大学 附属第一医院骨科,福州 350005
Author(s):
-
关键词:
脊柱炎 化脓 文献综述
Keywords:
-
分类号:
R681.51
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1] Issa K,Diebo B G,Faloon M,et al.The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013[J].Clin Spine Surg,2018,31(2):102-108.
[2] Akiyama T,Chikuda H,Yasunaga H,et al.Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database[J].BMJ Open,2013, 3(3):e002412.
[3] D'Agostino C,Scorzolini L,Massetti A P,et al.A seven-year prospective study on spondylodiscitis:epidemiological and microbiological features[J].Infection,2010,38(2):102-107.
[4] Kehrer M,Pedersen C,Jensen T G,et al.Increasing incidence of pyogenic spondylodiscitis:a 14-year population-based study[J].J Infect,2014,68(4):313-320.
[5] Rutges J P,Kempen D H,van Dijk M,et al.Outcome of conservative and surgical treatment of pyogenic spondylodiscitis:a systematic literature review[J].Eur Spine J,2016,25(4):983-999.
[6] Pola E,Logroscino C A,Gentiempo M,et al.Medical and surgical treatment of pyogenic spondylodiscitis[J].Eur Rev Med Pharmacol Sci,2012,16(Suppl 2):35-49.
[7] Gouliouris T,Aliyu S H,Brown N M.Spondylodiscitis:update on diagnosis and management[J].J Antimicrob Chemother,2010,65(S3):11-24.
[8] Zimmerli W.Clinical practice.Vertebral osteomyelitis[J].N Engl J Med,2010,362(11):1022-1029.
[9] Mylona E,Samarkos M,Kakalou E,et al.Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics[J].Semin Arthritis Rheum,2009,39(1):10-17.
[10] Kwon J W,Hyun S J,Han S H,et al.Pyogenic vertebral osteomyelitis:clinical features, diagnosis, and treatment[J].Korean J Spine,2017,14(2):27-34.
[11] Sendi P,Bregenzer T,Zimmerli W.Spinal epidural abscess in clinical practice[J]. QJM,2008,101(1):1-12.
[12] Cheung W Y,Luk K D.Pyogenic spondylitis[J].Int Orthop,2012,36(2):397-404.
[13] Cottle L, Riordan T.Infectious spondylodiscitis[J]. J Infect,2008,56(6):401-412.
[14] Maharajan K,Patro D K,Menon J, et al.Serum procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis[J].J Orthop Surg Res,2013,8:19.
[15] Jeong D K,Lee H W,Kwon Y M.Clinical value of procalcitonin in patients with spinal infection[J].J Korean Neurosurg Soc,2015,58(3):271-275.
[16] Maus U,Andereya S,Gravius S,et al.Procalcitonin as diagnostic tool for the monitoring of spondylodiscitis[J].Z Orthop Unfall,2009,147(1):59-64.
[17] Acosta F L Jr,Chin C T,Quinones-Hinojosa A,et al.Diagnosis and management of adult pyogenic osteomyelitis of the cervical spine[J]. Neurosurg Focus,2004,17(6):E2.
[18] Frel M,Bialecki J,Wieczorek J,et al.Magnetic resonance imaging in differentatial diagnosis of pyogenic spondylodiscitis and tuberculous spondylodiscitis[J].Pol J Radiol,2017,82:71-87.
[19] Lee K Y.Comparison of pyogenic spondylitis and tuberculous spondylitis[J].Asian Spine J,2014,8(2):216-223.
[20] Harada Y,Tokuda O,Matsunaga N.Magnetic resonance imaging characteristics of tuberculous spondylitis vs. pyogenic spondylitis[J].Clin Imaging,2008,32(4):303-309.
[21] Stumpe K D,Zanetti M,Weishaupt D,et al.FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging[J].AJR Am J Roentgenol,2002,179(5):1151-1157.
[22] Kouijzer I J E,Scheper H,de Rooy J W J,et al.The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis-a prospective study[J].Eur J Nucl Med Mol Imaging,2018,45(5):798-805.
[23] Bae J Y,Kim C J,Kim U J,et al.Concordance of results of blood and tissue cultures from patients with pyogenic spondylitis:a retrospective cohort study[J].Clin Microbiol Infect,2018,24(3):279-282.
[24] Kim C J, Kang S J, Choe P G,et al.Which tissues are best for microbiological diagnosis in patients with pyogenic vertebral osteomyelitis undergoing needle biopsy[J].Clin Microbiol Infect,2015,21(10):931-935.
[25] Ahuja N,Sharma H.The effectiveness of computed tomography- guided biopsy for the diagnosis of spondylodiscitis: an analysis of variables affecting the outcome[J].Eur Rev Med Pharmacol Sci,2017,21(9):2021-2026.
[26] Foreman S C,Schwaiger B J,Gempt J,et al.MR and CT imaging to optimize CT-guided biopsies in suspected spondylodiscitis[J].World Neurosurg,2017,99:726-734.
[27] Spira D,Germann T,Lehner B,et al.CT-guided biopsy in suspected spondylodiscitis-The association of paravertebral inflammation with microbial pathogen detection[J].PLoS One,2016,11(1):e0146399.
[28] Hau A, Kim I, Kattapuram S, et al.Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions[J].Skeletal Radiol,2002,31(6):349-353.
[29] Choi S H,Sung H,Kim S H,et al.Usefulness of a direct 16S rRNA gene PCR assay of percutaneous biopsies or aspirates for etiological diagnosis of vertebral osteomyelitis[J].Diagn Microbiol Infect Dis,2014,78(1):75-78.
[30] Sheikh A F,Khosravi A D,Goodarzi H,et al.Pathogen identification in suspected cases of pyogenic spondylodiscitis[J].Front Cell Infect Microbiol,2017,7:60.
[31] Kang S J,Jang H C,Jung S I,et al.Clinical characteristics and risk factors of pyogenic spondylitis caused by gram-negative bacteria[J].PLoS One,2015,10(5): e0127126.
[32] Viezens L,Schaefer C,Helmers R,et al.Spontaneous pyogenic spondylodiscitis in the thoracic or lumbar spine: A retrospective cohort study comparing the safety and efficacy of minimally invasive and open surgery over a nine-year period[J].World Neurosurg,2017,102:18-27.
[33] Herren C,Jung N,Pishnamaz M,et al.Spondylodiscitis: diagnosis and treatment options[J].Dtsch Arztebl Int,2017,114(51/52):875-882.
[34] Kehrer M,Pedersen C,Jensen T G,et al.Increased short- and long-term mortality among patients with infectious spondylodiscitis compared with a reference population[J]. Spine J,2015,15(6):1233-1240.
[35] Viale P, Furlanut M, Scudeller L,et al.Treatment of pyogenic(non-tuberculous)spondylodiscitis with tailored high-dose levoxacin plus rifampicin[J].Int J Antimicrob Agents.2009,33(4):379-382.
[36] Cordero-Delgado D A, Moheno-Gallardo A J, Torres-González R,et al.Evidence and recommendation of empirical antimicrobial treatment in pyogenic spondylodiscitis:systematic review[J].Rev Med Inst Mex Seguro Soc,2017,55(Suppl 1):S6-S13.
[37] Seyman D,Berk H,Sepln-Ozen N,et al.Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis[J].Infect Dis(Lond),2015,47(11):783-788.
[38] Desoutter S,Cottier J P,Ghout I,et al.Susceptibility pattern of microorganisms isolated by percutaneous needle biopsy in nonbacteremic pyogenic vertebral osteomyelitis[J].Antimicrob Agents Chemother,2015,59(12):7700-7706.
[39] Bernard L,Dinh A,Ghout I,et al.Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis:an open-label, non-inferiority, randomised, controlled trial[J].Lancet,2015,385(9971):875-882.
[40] Berbari E F,Kanj S S,Kowalski T J,et al.2015 Infectious Diseases Society of America(IDSA)clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults[J].Clin Infect Dis,2015,61(6):e26-46.
[41] Park K H,Cho O H,Lee J H,et al.Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence[J]. Clin Infect Dis,2016,62(10):1262-1269.
[42] McHenry M C,Easley K A,Locker G A.Vertebral osteomyelitis:long-term outcome for 253 patients from 7 Cleveland-area hospitals[J]. Clin Infect Dis, 2002,34:1342-1350.
[43] Lora-Tamayo J, Murillo O.Shorter treatments for vertebral osteomyelitis[J].Lancet,2015,385(9971):836-837.
[44] Aboobakar R, Cheddie S, Singh B.Surgical management of psoas abscess in the Human Immunodeficiency Virus era[J].Asian J Surg,2018,41(2):131-135.
[45] Matsumoto T,Yamagami T,Morishita H,et al.CT-guided percutaneous drainage within intervertebral space for pyogenic spondylodiscitis with psoas abscess[J].Acta Radiol,2012,53(1):76-80.
[46] Jean M,Irisson J O,Gras G,et al.Diagnostic delay of pyogenic vertebral osteomyelitis and its associated factors[J].Scand J Rheumatol,2017,46(1):64-68.
[47] Dinh A,Jean M,Bouchand F,et al.Impact of anti-inflammatory drugs on pyogenic vertebral osteomyelitis:a prospective cohort study[J].Int J Rheumatol,2016:9345467.
[48] Chen W H,Jiang L S,Dai L Y. Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation[J].Eur Spine J,2007,16(9):1307-1016.
[49] Guerado E,Cervan A M.Surgical treatment of spondylodiscitis. An update[J].Int Orthop,2012,36(2):413-420.
[50] Si M,Yang Z P,Li Z F,et al.Anterior versus posterior fixation for the treatment of lumbar pyogenic vertebral osteomyelitis[J].Orthopedics,2013,36(6):831-836.
[51] Talia A J,Wong M L,Lau H C,et al.Safety of instrumentation and fusion at the time of surgical debridement for spinal infection[J].J Clin Neurosci,2015,22(7):1111-1116.
[52] Shiban E,Janssen I,da Cunha P R,et al.Safety and efficacy of polyetheretherketone(PEEK)cages in combination with posterior pedicel screw fixation in pyogenic spinal infection[J].Acta Neurochir(Wien),2016,158(10):1851-1857.
[53] Noh S H, Zhang H Y, Lim H S,et al.Decompression alone versus fusion for pyogenic spondylodiscitis[J].Spine J,2017,17(8):1120-1126.
[54] Lin T Y,Tsai T T,Lu M L,et al.Comparison of two-stage open versus percutaneous pedicle screw fixation in treating pyogenic spondylodiscitis[J].BMC Musculoskelet Disord, 2014,15:443.
[55] Pola E, Autore G, Formica V M,et al.New classification for the treatment of pyogenic spondylodiscitis:validation study on a population of 250 patients with a follow-up of 2 years[J].Eur Spine J,2017,26(S4):479-488.

相似文献/References:

[1]林欣欣,吴文华,高锦团,等.强直性脊柱炎患者的运动协调性改变[J].福建医科大学学报,2015,49(03):163.
 LIN Xinxin,WU Wenhua,GAO Jintuan,et al.The Change of Movement Coordination in Patients with Ankylosing Spondylitis[J].Journal of Fujian Medical University,2015,49(01):163.

备注/Memo

备注/Memo:
收稿日期: 2018-10-10 作者简介: 陈秋洪,男,福建医科大学2017级临床医学专业硕士研究生 通讯作者: 陈 雷.Email:fjydgk@126.com
更新日期/Last Update: 2020-01-30